Cecha
Early onset of puberty
Nazwa kliniczna: Precocious puberty
The onset of secondary sexual characteristics before a normal age. Although it is difficult to define normal age ranges because of the marked variation with which puberty begins in normal children, precocious puberty can be defined as the onset of puberty before the age of 8 years in girls or 9 years in boys.
Podsumowanie
- Znana także jako
- Early puberty
- Układ organizmu
- Abnormality of the endocrine system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Early onset of puberty, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test156 genów powiązanych z Early onset of puberty
Zmiany w tych genach powodują rzadkie choroby, w których występuje Early onset of puberty. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| EPG5ectopic P-granules 5 autophagy tethering factor | Zawsze | W 1 chorobie |
| FEM1Bfem-1 homolog B | Zawsze | W 1 chorobie |
| ITPR1inositol 1,4,5-trisphosphate receptor type 1 | Zawsze | W 1 chorobie |
| KDM2Blysine demethylase 2B | Zawsze | W 1 chorobie |
| DLK1delta like non-canonical Notch ligand 1 | Bardzo często (80–99%) | W 3 chorobach |
| GNASGNAS complex locus | Bardzo często (80–99%) | W 2 chorobach |
| HYMAIhydatidiform mole associated and imprinted | Bardzo często (80–99%) | W 1 chorobie |
| LHCGRluteinizing hormone/choriogonadotropin receptor | Bardzo często (80–99%) | W 1 chorobie |
| LMNAlamin A/C | Bardzo często (80–99%) | W 1 chorobie |
| MEG3maternally expressed 3 | Bardzo często (80–99%) | W 3 chorobach |
| PLAGL1PLAG1 like zinc finger 1 | Bardzo często (80–99%) | W 1 chorobie |
| RTL1retrotransposon Gag like 1 | Bardzo często (80–99%) | W 3 chorobach |
| ASXL3ASXL transcriptional regulator 3 | Często (30–79%) | W 1 chorobie |
| CDONcell adhesion associated, oncogene regulated | Często (30–79%) | W 1 chorobie |
| CRIPTOcripto, EGF-CFC family member | Często (30–79%) | W 1 chorobie |
| CYP11B1cytochrome P450 family 11 subfamily B member 1 | Często (30–79%) | W 1 chorobie |
| DISP1dispatched RND transporter family member 1 | Często (30–79%) | W 1 chorobie |
| DLL1delta like canonical Notch ligand 1 | Często (30–79%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Często (30–79%) | W 1 chorobie |
| FOXH1forkhead box H1 | Często (30–79%) | W 1 chorobie |
| FREM1FRAS1 related extracellular matrix 1 | Często (30–79%) | W 1 chorobie |
| GAS1growth arrest specific 1 | Często (30–79%) | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Często (30–79%) | W 1 chorobie |
| HNRNPRheterogeneous nuclear ribonucleoprotein R | Często (30–79%) | W 1 chorobie |
| IQSEC2IQ motif and Sec7 domain ArfGEF 2 | Często (30–79%) | W 1 chorobie |
| NODALnodal growth differentiation factor | Często (30–79%) | W 1 chorobie |
| PIGFphosphatidylinositol glycan anchor biosynthesis class F | Często (30–79%) | W 1 chorobie |
| PTCH1patched 1 | Często (30–79%) | W 1 chorobie |
| SHHsonic hedgehog signaling molecule | Często (30–79%) | W 1 chorobie |
| SIX3SIX homeobox 3 | Często (30–79%) | W 1 chorobie |
| STILSTIL centriolar assembly protein | Często (30–79%) | W 1 chorobie |
| TFE3transcription factor binding to IGHM enhancer 3 | Często (30–79%) | W 1 chorobie |
| TGIF1TGFB induced factor homeobox 1 | Często (30–79%) | W 1 chorobie |
| ZIC2Zic family zinc finger 2 | Często (30–79%) | W 1 chorobie |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Czasami (5–29%) | W 1 chorobie |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Czasami (5–29%) | W 1 chorobie |
| CLIP2CAP-Gly domain containing linker protein 2 | Czasami (5–29%) | W 1 chorobie |
| CNTNAP2contactin associated protein 2 | Czasami (5–29%) | W 1 chorobie |
| CTSHcathepsin H | Czasami (5–29%) | W 1 chorobie |
| DDX3XDEAD-box helicase 3 X-linked | Czasami (5–29%) | W 2 chorobach |
Pokaż jeszcze 116 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Czasami (5–29%) | W 1 chorobie |
| EIF4Heukaryotic translation initiation factor 4H | Czasami (5–29%) | W 1 chorobie |
| ELNelastin | Czasami (5–29%) | W 1 chorobie |
| EXT2exostosin glycosyltransferase 2 | Czasami (5–29%) | W 1 chorobie |
| FBXO22F-box protein 22 | Czasami (5–29%) | W 1 chorobie |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Czasami (5–29%) | W 1 chorobie |
| GLI3GLI family zinc finger 3 | Czasami (5–29%) | W 2 chorobach |
| GRB10growth factor receptor bound protein 10 | Czasami (5–29%) | W 1 chorobie |
| GTF2Igeneral transcription factor IIi | Czasami (5–29%) | W 1 chorobie |
| GTF2IRD1GTF2I repeat domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| GTF2IRD2GTF2I repeat domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| H4C5H4 clustered histone 5 | Czasami (5–29%) | W 1 chorobie |
| H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase | Czasami (5–29%) | W 2 chorobach |
| HCRThypocretin neuropeptide precursor | Czasami (5–29%) | W 1 chorobie |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Czasami (5–29%) | W 1 chorobie |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Czasami (5–29%) | W 1 chorobie |
| HRASHRas proto-oncogene, GTPase | Czasami (5–29%) | W 3 chorobach |
| HSD11B1hydroxysteroid 11-beta dehydrogenase 1 | Czasami (5–29%) | W 1 chorobie |
| INSRinsulin receptor | Czasami (5–29%) | W 3 chorobach |
| KDM6Alysine demethylase 6A | Czasami (5–29%) | W 1 chorobie |
| KMT2Blysine methyltransferase 2B | Czasami (5–29%) | W 1 chorobie |
| KMT2Dlysine methyltransferase 2D | Czasami (5–29%) | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Czasami (5–29%) | W 1 chorobie |
| LIMK1LIM domain kinase 1 | Czasami (5–29%) | W 1 chorobie |
| MAB21L2mab-21 like 2 | Czasami (5–29%) | W 1 chorobie |
| MAGEL2MAGE family member L2 | Czasami (5–29%) | W 5 chorobach |
| MC2Rmelanocortin 2 receptor | Czasami (5–29%) | W 1 chorobie |
| METTL27methyltransferase like 27 | Czasami (5–29%) | W 1 chorobie |
| MIA3MIA SH3 domain ER export factor 3 | Czasami (5–29%) | W 1 chorobie |
| MOGmyelin oligodendrocyte glycoprotein | Czasami (5–29%) | W 1 chorobie |
| MRAPmelanocortin 2 receptor accessory protein | Czasami (5–29%) | W 1 chorobie |
| MSL3MSL complex subunit 3 | Czasami (5–29%) | W 1 chorobie |
| NCF1neutrophil cytosolic factor 1 | Czasami (5–29%) | W 1 chorobie |
| NFIXnuclear factor I X | Czasami (5–29%) | W 1 chorobie |
| NNTnicotinamide nucleotide transhydrogenase | Czasami (5–29%) | W 2 chorobach |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Czasami (5–29%) | W 1 chorobie |
| NRASNRAS proto-oncogene, GTPase | Czasami (5–29%) | W 1 chorobie |
| P2RY11purinergic receptor P2Y11 | Czasami (5–29%) | W 1 chorobie |
| PCNTpericentrin | Czasami (5–29%) | W 2 chorobach |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Czasami (5–29%) | W 1 chorobie |
| PLAAT3phospholipase A and acyltransferase 3 | Czasami (5–29%) | W 1 chorobie |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Czasami (5–29%) | W 1 chorobie |
| RAI1retinoic acid induced 1 | Czasami (5–29%) | W 1 chorobie |
| RFC2replication factor C subunit 2 | Czasami (5–29%) | W 1 chorobie |
| SIM1SIM bHLH transcription factor 1 | Czasami (5–29%) | W 1 chorobie |
| SLC35A2solute carrier family 35 member A2 | Czasami (5–29%) | W 1 chorobie |
| SMAD4SMAD family member 4 | Czasami (5–29%) | W 1 chorobie |
| SOX6SRY-box transcription factor 6 | Czasami (5–29%) | W 1 chorobie |
| SPENspen family transcriptional repressor | Czasami (5–29%) | W 1 chorobie |
| SRCAPSnf2 related CREBBP activator protein | Czasami (5–29%) | W 1 chorobie |
| STARsteroidogenic acute regulatory protein | Czasami (5–29%) | W 1 chorobie |
| STX1Asyntaxin 1A | Czasami (5–29%) | W 1 chorobie |
| TBL2transducin beta like 2 | Czasami (5–29%) | W 1 chorobie |
| TMEM270transmembrane protein 270 | Czasami (5–29%) | W 1 chorobie |
| TNFSF4TNF superfamily member 4 | Czasami (5–29%) | W 1 chorobie |
| TNRC6Btrinucleotide repeat containing adaptor 6B | Czasami (5–29%) | W 1 chorobie |
| TONSLtonsoku like, DNA repair protein | Czasami (5–29%) | W 1 chorobie |
| TXNRD2thioredoxin reductase 2 | Czasami (5–29%) | W 1 chorobie |
| VPS37DVPS37D subunit of ESCRT-I | Czasami (5–29%) | W 1 chorobie |
| ZNF365zinc finger protein 365 | Czasami (5–29%) | W 1 chorobie |
| ZNF526zinc finger protein 526 | Czasami (5–29%) | W 1 chorobie |
| ARXaristaless related homeobox | Rzadko (1–4%) | W 1 chorobie |
| CACNA1Ecalcium voltage-gated channel subunit alpha1 E | Rzadko (1–4%) | W 1 chorobie |
| CASKcalcium/calmodulin dependent serine protein kinase | Rzadko (1–4%) | W 1 chorobie |
| CDKL5cyclin dependent kinase like 5 | Rzadko (1–4%) | W 1 chorobie |
| DMXL2Dmx like 2 | Rzadko (1–4%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Rzadko (1–4%) | W 1 chorobie |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Rzadko (1–4%) | W 1 chorobie |
| GNAO1G protein subunit alpha o1 | Rzadko (1–4%) | W 1 chorobie |
| GRIN1glutamate ionotropic receptor NMDA type subunit 1 | Rzadko (1–4%) | W 1 chorobie |
| GRM7glutamate metabotropic receptor 7 | Rzadko (1–4%) | W 1 chorobie |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Rzadko (1–4%) | W 1 chorobie |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Rzadko (1–4%) | W 1 chorobie |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Rzadko (1–4%) | W 1 chorobie |
| KMT2Clysine methyltransferase 2C | Rzadko (1–4%) | W 1 chorobie |
| LGI1leucine rich glioma inactivated 1 | Rzadko (1–4%) | W 1 chorobie |
| NDNnecdin, MAGE family member | Rzadko (1–4%) | W 3 chorobach |
| NEUROD2neuronal differentiation 2 | Rzadko (1–4%) | W 1 chorobie |
| NF1neurofibromin 1 | Rzadko (1–4%) | W 1 chorobie |
| OCA2OCA2 melanosomal transmembrane protein | Rzadko (1–4%) | W 3 chorobach |
| PDE11Aphosphodiesterase 11A | Rzadko (1–4%) | W 1 chorobie |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Rzadko (1–4%) | W 1 chorobie |
| PIGPphosphatidylinositol glycan anchor biosynthesis class P | Rzadko (1–4%) | W 1 chorobie |
| PIGQphosphatidylinositol glycan anchor biosynthesis class Q | Rzadko (1–4%) | W 1 chorobie |
| PLCB1phospholipase C beta 1 | Rzadko (1–4%) | W 1 chorobie |
| PNKPpolynucleotide kinase 3'-phosphatase | Rzadko (1–4%) | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Rzadko (1–4%) | W 1 chorobie |
| RHOBTB2Rho related BTB domain containing 2 | Rzadko (1–4%) | W 1 chorobie |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Rzadko (1–4%) | W 1 chorobie |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Rzadko (1–4%) | W 1 chorobie |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Rzadko (1–4%) | W 2 chorobach |
| SIK1salt inducible kinase 1 | Rzadko (1–4%) | W 1 chorobie |
| SLC12A5solute carrier family 12 member 5 | Rzadko (1–4%) | W 1 chorobie |
| SLC25A22solute carrier family 25 member 22 | Rzadko (1–4%) | W 2 chorobach |
| SLC32A1solute carrier family 32 member 1 | Rzadko (1–4%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Rzadko (1–4%) | W 3 chorobach |
| TBC1D24TBC1 domain family member 24 | Rzadko (1–4%) | W 1 chorobie |
| TRIM8tripartite motif containing 8 | Rzadko (1–4%) | W 1 chorobie |
| CPLX1complexin 1 | Nie odnotowano | W 1 chorobie |
| CTBP1C-terminal binding protein 1 | Nie odnotowano | W 1 chorobie |
| DHCR77-dehydrocholesterol reductase | Nie odnotowano | W 1 chorobie |
| FGFRL1fibroblast growth factor receptor like 1 | Nie odnotowano | W 1 chorobie |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Nie odnotowano | W 1 chorobie |
| IFNGinterferon gamma | Nie odnotowano | W 1 chorobie |
| LETM1leucine zipper and EF-hand containing transmembrane protein 1 | Nie odnotowano | W 1 chorobie |
| MKRN3makorin ring finger protein 3 | Nie odnotowano | W 1 chorobie |
| NPAP1nuclear pore associated protein 1 | Nie odnotowano | W 1 chorobie |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Nie odnotowano | W 1 chorobie |
| NSD2nuclear receptor binding SET domain protein 2 | Nie odnotowano | W 1 chorobie |
| PWAR1Prader Willi/Angelman region RNA 1 | Nie odnotowano | W 1 chorobie |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Nie odnotowano | W 1 chorobie |
| RAB23RAB23, member RAS oncogene family | Nie odnotowano | W 1 chorobie |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Nie odnotowano | W 1 chorobie |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Nie odnotowano | W 1 chorobie |
| TSC1TSC complex subunit 1 | Nie odnotowano | W 1 chorobie |
| TSC2TSC complex subunit 2 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni